Study of Collagenase-3 Levels in Rheumatoid Arthritis Patients with and without Type 2 Diabetes Mellitus
Main Article Content
Abstract
This research sought early signs of type 2 diabetes mellitus (T2DM) in rheumatoid arthritis (RA) patients. The current research's objectives are to identify collagenase-3 (CL-3) in RA patients with and without T2DM as a disease complication, compare these findings to those of a control group, and ascertain whether or not CL-3 correlates with all of the parameters that were examined in each group. In the present research, (150) participants all between the ages of 30 and 50 were divided into three groups: (G1) control (N=50), (G2) RA (N=50), and (G3) RA with T2DM (N=50). Collagenase-3, glycated hemoglobin (HbA1c), erythrocyte sedimentaion (ESR), anti-cyclic citrullinated peptide (anti-CCP), and rheumatoid factor (RF) were all measured in this experiment. Data revealed that (G2) and (G3) had considerably greater RF, anti-CCP, and ESR levels than (G1) in comparison. Compared to G2, there was a very obvious increase in G3. The results of the HbA1c test showed that (G2) increased non-significantly compared to (G1), but (G3) was much more than (G2) and (G1). The levels of CL-3 in (G2) and (G3) were found to be significantly higher than in controls (G1) in these groups. A well-related biomarker with these patients was shown by CL-3, demonstrating a strong positive or negative association with all metrics for all groups. This suggests that the best medicine and therapy will be available for these patients. These results suggest that CL-3 might be a biochemical diagnostic for RA patients' early diagnosis of diabetes.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
licenseTerms
Publication Dates
Received
Accepted
Published Online First
References
Smolen, J.S.; Aletaha D.; Barton A.; Burmester G.R.; Emery, P.; Firestein G.S. Rheumatoid Arthritis. Nature Review Disease Primers 2018, 4(1), 18001. https://doi.org/10.1038/nrdp.2018.1.
Omran, R.H.; Zahra'a, A.A.; Alrawi, A.A. Evaluation of Some New Cytokines in Rheumatoid Arthritis. Journal of the Faculty of Medicine Baghdad 2022, 64(3), 159-162.
https://doi.org/10.32007/jfacmedbagdad.6431963.
Lestarini, A.; Aryastuti, A.A.; Witari, N.P.; Sutarka, I.W.; Wardani, N.W.; Hastuti, P.; Sadewa, A.H. MCP-1 Serum Levels Were Higher in Patient with Diabetic Nephropathy among Balinese. Indian Journal of Public Health 2020, 11(1), 1351.
https://www.researchgate.net/profile/Asri-Lestarini/publication/342688022.
Mengshol, J.A.; Mix, K.S.; Brinckerhoff C.E. Matrix Metalloproteinases as Therapeutic Targets in Arthritic Diseases: Bull’s-Eye or Missing the Mark. Arthritis and Rheumatism 2002, 46(1), 13–20. https://doi.org/10.1002/art.497.
Cui, N.; Hu, M.; Khalil, R.A. Chapter One-Biochemical and Biological Attributes of Matrix Metalloproteinases. Progress in Molecular Biology and Translational Science 2017, 147(1), 1–73.
https://doi.org/10.1016/bs.pmbts.2017.02.005.
Schieir, O.; Tosevski, C.; Glazier, R.H.; Hogg-Johnson, S.; Badley, E.M. Incident Myocardial Infarction Associated aith Major Types of Arthritis in the General Population: A Systematic Review and Meta-Analysis. Annals of the Rheumatic Diseases 2017, 76(8), 1404–1396.
https://doi.org/10.1136/annrheumdis-2016-210275.
Al-Ameri, M.A.; Al-Rubaei, Z. Study of Tumor Necrosis Factor-β (Lymphotoxin) and Cell Death Receptor (TNFR-2) in Rhumatiod Arthritis with Type 2 Diabetes Mellitus. Pakistan Journal of Medical and Health Sciences 2022, 16(6), 468–468. https://doi.org/10.53350/pjmhs22166468.
Stahle-Backdahl, M.; Sandstedt, B.; Bruce, K.; Lindahl, A.; Jimenez, M.G.; Vega, J.A.; López-Otín C. Collagenase-3 (MMP-13) Is Expressed During Human Fetalossification and Re-Expressed in Postnatal Bone Remodeling and in Rheumatoid Arthritis. Laboratory Investigation 1997, 76(5), 717–728. https://europepmc.org/article/med/9166290.
Boneva, B.; Ralchev, N.; Ganova, P.; Tchorbanov, A.; Mihaylova, N. CollagenaseInduced Mouse Model of Osteoarthritis—A Thorough Flow Cytometry Analysis. Life 2022, 12(11), 1938.
https://doi.org/10.3390/life12111938.
Xin, X.; Tan, Q.; Li, F.; Chen, Z.; Zhang, K.; Li, F.; Yang, B.; Xing, Z.; Zhou, F.; Tian, Y.; Lv, Y. Potential Value of Matrix Metalloproteinase-13 as a Biomarker for Osteoarthritis. Frontiers in Surgery 2021, 8(1), 528. https://doi.org/10.3389/fsurg.2021.750047.
Hussein, W.A. The Quality of Life in Patients with Rheumatoid Arthritis in Baghdad, 2017: A Cross-Sectional Study. International Journal of Medical Research and Health Sciences 2017, 6(11), 20-34. https://www.indianjournals.com/ijor.aspx?target=ijor:ijmrhs&volume.
Kang, E.H.; Ha, Y.J.; Lee, Y.J. Autoantibody Biomarkers in Rheumatic Diseases. International Journal of Molecular Sciences 2020, 21(4), 1382. https://doi.org/10.3390/ijms21041382.
Nazar, L.; Eiman, A.A. Study of IL-33 and IL-1R4 in Iraqi Rheumatoid Arthritis Female Patient's with and without Dyslipidemia Prone to Atherosclerosis. Ibn AL-Haitham Journal For Pure and Applied Sciences 2019, 32(1), 48–56. https://doi.org/10.30526/32.1.1920.
Shapiro, S.C. Biomarkers in Rheumatoid Arthritis. Cureus 2021, 13(5), e15063.
https://doi.org/10.7759/cureus.15063.
Lee, Y.H.; Song, G.G. Causal Association between Rheumatoid Arthritis with the Increased Risk of Type 2 Diabetes: A Mendelian Randomization Analysis. Journal of Rheumatic Diseases 2019, 26(2), 131-136. https://doi.org/10.4078/jrd.2019.26.2.131.
Tian, Z.; Mclaughlin, J.; Verma, A.; Chinoy, H.; Heald, A. H. The Relationship between Rheumatoid Arthritis and Diabetes Mellitus: A Systematic Review and Metaanalysis. Cardiovascular Endocrinology and Metabolism 2021, 10(2), 125. https://doi.org/10.1097/XCE.0000000000000244.
Ahmad, R.; Zgair, A. Immunological and Biological Manifestation of Rheumatoid Arthritis Patient in Iraq. Indian Journal of Forensic Medicine and Toxicology 2021, 15(4), 1344-1350.
https://pdfs.semanticscholar.org/66ac/c786bd5ad9db2bb642a.
Iwasaki, T.; Nakabo, S.; Terao, C.; Murakami, K.; Nakashima, R.; Hashimoto, M.; Imura, Y.; Yukawa, N.; Yoshifuji, H.; Miura, Y.; Yurugi, K.; Maekawa, T.; van Delft, M. A. M.; Trouw, L.A.; Fujii, T.; Mimori, T.; Ohmura, K. Long-Term Follow-Up of Patients with Anti-Cyclic Citrullinated Peptide Antibody-Positive Connective Tissue Disease: A Retrospective Observational Study Including Information on the HLA-DRB1 Allele and Citrullination Dependency. Arthritis Research and Therapy 2020, 22(1), 1-9. https://doi.org/10.1186/s13075-020-02351-4.
Khidhir, R.M.; Al-Jubouri, R.H. The Study of Tempromandibularjoint Disorders and Anti-Cyclic Citrullinated Peptide Antibodies in Serum and Saliva of Patients with Rheumatoid Arthritis. Journal of Baghdad College of Dentistry 2013, 25(Special Is), 67-71.
https://www.jbcd.uobaghdad.edu.iq/index.php/jbcd/article/view/201.
Haydar, A.A.; Abdullah, I.R. The Impact of Therapies as Monotherapy with Combined Therapy on Novel and Traditional Biomarkers in Patients with Rheumatoid Arthritis. Zanco Journal of Medical Sciences 2020, 24(3), 325-332. https://doi.org/10.15218/zjms.2020.038.
Oliveira, T.H.C.; Marques, P.E.; Proost, P.; Teixeira, M.M.M. Neutrophils: A Cornerstone of Liver Ischemia and Reperfusion Injury. Laboratory Investigation 2018, 98(1), 51–62.
https://doi.org/10.1038/labinvest.2017.90.
Jabłońska-Trypuć, A.; Matejczyk, M.; Rosochacki, S. Matrix Metalloproteinases (Mmps), The Main Extracellular Matrix (ECM) Enzymes in Collagen Degradation, as a Target for Anticancer Drugs. Journal of Enzyme Inhibition and Medicinal Chemistry 2016, 31(1), 177–183.
https://doi.org/10.3109/14756366.2016.1161620.
Luo, S.; Li, W.; Wu, W.; Shi, Q. Elevated Expression of MMP8 and MMP9 Contributes to Diabetic Osteoarthritis Progression in a Rat Model. Journal of Orthopaedic Surgery and Research 2021, 16(1),1-9. https://doi.org/10.1186/s13018-021-02208-9.
Wilkinson, D.J.; Falconer, A.M.; Wright, H.L.; Lin, H.; Yamamoto, K.; Cheung, K.; Charlton, S.H.; Arques, M.D.C.; Janciauskiene, S.; Refaie, R.; Rankin, K.S. Matrix Metalloproteinase‐13 is Fully Activated by Neutrophil Elastase and Inactivates Its Serpin Inhibitor, Alpha‐1 Antitrypsin: Implications for Osteoarthritis. The FEBS journal 2022, 289(1), 121-139. https://doi.org/10.1111/febs.16127.
Fosang, A.J.; Last, K.; Knauper, V.; Murphy, G.; Neame, P.J. Degradation of Cartilage Aggrecan by Collagenase-3 (MMP-13). FEBS Letters 1996, 380(1-2), 17-20. https://doi.org/10.1016/0014-5793(95)01539-6.
Li, N.G.; Shi, Z.H.; Tang, Y.P.; Wang, Z.J.; Song, S.L.; Qian, L.H.; Qian, D.W.; Duan, J.A. New Hope for the Treatment of Osteoarthritis Through Selectiveinhibition of MMP-13. Current Medicinal Chemistry 2011, 18(7), 977–1001. https://doi.org/10.2174/092986711794940905.
Nasr, M.H.; Hassan, B.A.R.; Othman, N.; Karuppannan, M.; Abdulaziz, N.B.; Mohammed, A.H.; Alsarani, M.A.; Eskembaji, M.H.; Aman, A.M.; Othman, G. Prevalence of Vitamin D Deficiency between Type 2 Diabetes Mellitus Patients and Non-Diabetics in the Arab Gulf. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022, 15(1), 647-657. https://doi.org/10.2147/DMSO.S350626.
Kouskoff, V.; Korganow, AS.; Duchatelle, V.; Degott, C.; Benoist, C.; Mathis, D. Organ-Specific Disease Provoked by Systemic Autoimmunity. Cell 1996, 87(5), 811–822. https://doi.org/10.1016/S0092-8674(00)81989-3.
Castrogiovanni, P.; Di Rosa, M.; Ravalli, S.; Castorina, A.; Guglielmino, C.; Imbesi, R.; Vecchio, M.; Drago, F.; Szychlinska, M.A.; Musumeci, G. Moderate Physical Activity As a Prevention Method for Knee Osteoarthritis and the Role of Synoviocytes as Biological Key. International Journal of Molecular Sciences 2019, 20(3), 511. https://doi.org/10.3390/ijms20030511.
Hu, Q.; Ecker, M. Overview of MMP-13 as a promising target for the treatment of osteoarthritis. International Journal of Molecular Sciences 2021, 22(4), 1742. https://doi.org/10.3390/ijms22041742.
Meehan, R.T.; Regan, E.A.; Hoffman, E.D.; Wolf, M.L.; Gill, M.T.; Crooks, J.L.; Parmar, P.J.; Scheuring, R.A.; Hill, J.C.; Pacheco, K.A.; Knight, V. Synovial Fluid Cytokines, Chemokines and MMP Levels in Osteoarthritis Patients with Knee Pain Display a Profile Similar to Many Rheumatoid Arthritis Patients. Journal of Clinical Medicine 2021, 10(21), 5027. https://doi.org/10.3390/jcm10215027.
Chan, C.M.; Macdonald, C.D.; Litherland, G.J.; Wilkinson, D.J.; Skelton, A.; EuropeFinner, G.N.; Rowan, A.D. Cytokine-Induced MMP13 Expression In Human Chondrocytes is Dependent on Activating Transcription Factor 3 (ATF3) Regulation. Journal of Biological Chemistry 2017, 292(5), 1625-1636. https://doi.org/10.1074/jbc.M116.756601.
Rowan, A. D.; Young, D. A.; Collagenase Gene Regulation by Pro-Inflammatory Cytokines in Cartilage. Frontiers in Bioscience-Landmark 2007, 12(1), 536-550. https://doi.org/10.2741/2080.
Catterall, J.B.; Carrere, S.; Koshy, P.J.T.; Degnan, B.A.; Shingleton, W.D.; Brinckerhoff, C.E.; Rowan, A.D. Synergistic Induction of Matrix Metalloproteinase 1 by Interleukin‐1α and Oncostatin M in Human Chondrocytes Involves Signal Transducer and Activator of Transcription and Activator Protein 1 Transcription Factors Via a Novel Mechanism. Arthritis and Rheumatism 2001, 44(10), 2296-2310.
https://doi.org/10.1002/1529-0131(200110)44:10%3C2296::AID-ART392%3E3.0.CO;2-9.
Litherland, G.J.; Elias, M.S.; Hui, W.; Macdonald, C.D.; Catterall, J.B.; Barter, M.J.; Rowan, A.D. Protein Kinase C Isoforms Ζ and Ι Mediate Collagenase Expression and Cartilage Destruction Via STAT3-and ERK-Dependent C-Fos Induction. Journal of Biological Chemistry 2010, 285(29), 22414-22425. https://doi.org/10.1074/jbc.M110.120121%20.
Litherland, G.J.; Dixon, C.; Lakey, R.L.; Robson, T.; Jones, D.; Young, D.A.; Rowan, A.D. Synergistic Collagenase Expression and Cartilage Collagenolysis are Phosphatidylinositol 3-Kinase/ Aktsignaling-Dependent. Journal of Biological Chemistry 2008, 283(29), 14221-14229. https://doi.org/10.1074/jbc.M710136200.